BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 35101048)

  • 1. Progress in cancer drug delivery based on AS1411 oriented nanomaterials.
    Tong X; Ga L; Ai J; Wang Y
    J Nanobiotechnology; 2022 Jan; 20(1):57. PubMed ID: 35101048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamer-Functionalized and Backbone Redox-Responsive Hyperbranched Polymer for Targeted Drug Delivery in Cancer Therapy.
    Zhuang Y; Deng H; Su Y; He L; Wang R; Tong G; He D; Zhu X
    Biomacromolecules; 2016 Jun; 17(6):2050-62. PubMed ID: 27113017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AS1411 Aptamer/Hyaluronic Acid-Bifunctionalized Microemulsion Co-Loading Shikonin and Docetaxel for Enhanced Antiglioma Therapy.
    Wang H; Zhu Z; Zhang G; Lin F; Liu Y; Zhang Y; Feng J; Chen W; Meng Q; Chen L
    J Pharm Sci; 2019 Nov; 108(11):3684-3694. PubMed ID: 31465736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel theranostic system of AS1411 aptamer-functionalized albumin nanoparticles loaded on iron oxide and gold nanoparticles for doxorubicin delivery.
    Baneshi M; Dadfarnia S; Shabani AMH; Sabbagh SK; Haghgoo S; Bardania H
    Int J Pharm; 2019 Jun; 564():145-152. PubMed ID: 30978484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery system using silica nanoparticles coated with chitosan and AS1411 for combination therapy of doxorubicin and antimiR-21.
    Khatami F; Matin MM; Danesh NM; Bahrami AR; Abnous K; Taghdisi SM
    Carbohydr Polym; 2021 Aug; 266():118111. PubMed ID: 34044928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pegylated magnetic mesoporous silica nanoparticles decorated with AS1411 Aptamer as a targeting delivery system for cytotoxic agents.
    Sakhtianchi R; Darvishi B; Mirzaie Z; Dorkoosh F; Shanehsazzadeh S; Dinarvand R
    Pharm Dev Technol; 2019 Nov; 24(9):1063-1075. PubMed ID: 30654677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aptamer-mediated synthesis of multifunctional nano-hydroxyapatite for active tumour bioimaging and treatment.
    Zhang W; Zhou R; Yang Y; Peng S; Xiao D; Kong T; Cai X; Zhu B
    Cell Prolif; 2021 Sep; 54(9):e13105. PubMed ID: 34382270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
    Mosafer J; Mokhtarzadeh A
    Curr Drug Deliv; 2018; 15(9):1323-1329. PubMed ID: 30039760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamer-Directed Specific Drug Delivery and Magnetic Resonance Imaging of Renal Carcinoma Cells In Vitro and In Vivo.
    Li J; Wang J; Sun D; Dai Y; Shen J; You J; Han C; Xu K
    J Biomed Nanotechnol; 2016 Aug; 12(8):1604-616. PubMed ID: 29342341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of delivering aptamer targeted nano-drugs into cells.
    Liu Y; Yang Y; Zhang Q; Lu D; Li S; Li J; Yang G; Shan Y
    J Mater Chem B; 2021 Jan; 9(4):952-957. PubMed ID: 33437980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AS1411 derivatives as carriers of G-quadruplex ligands for cervical cancer cells.
    Figueiredo J; Lopes-Nunes J; Carvalho J; Antunes F; Ribeiro M; Campello MPC; Paulo A; Paiva A; Salgado GF; Queiroz JA; Mergny JL; Cruz C
    Int J Pharm; 2019 Sep; 568():118511. PubMed ID: 31301466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G-quadruplex oligonucleotide AS1411 as a cancer-targeting agent: Uses and mechanisms.
    Bates PJ; Reyes-Reyes EM; Malik MT; Murphy EM; O'Toole MG; Trent JO
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1414-1428. PubMed ID: 28007579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells.
    Zhou W; Zhou Y; Wu J; Liu Z; Zhao H; Liu J; Ding J
    J Drug Target; 2014 Jan; 22(1):57-66. PubMed ID: 24156476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AS1411 Aptamer-Decorated Biodegradable Polyethylene Glycol-Poly(lactic-co-glycolic acid) Nanopolymersomes for the Targeted Delivery of Gemcitabine to Non-Small Cell Lung Cancer In Vitro.
    Alibolandi M; Ramezani M; Abnous K; Hadizadeh F
    J Pharm Sci; 2016 May; 105(5):1741-1750. PubMed ID: 27039356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Magnetic T7 Peptide&AS1411 Aptamer-Modified Microemulsion for Triple Glioma-Targeted Delivery of Shikonin and Docetaxel.
    Wang H; Chen W; Wu G; Kong J; Yuan S; Chen L
    J Pharm Sci; 2021 Aug; 110(8):2946-2954. PubMed ID: 33785350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High affinity of AS1411 toward copper; its application in a sensitive aptasensor for copper detection.
    Bahreyni A; Ramezani M; Alibolandi M; Hassanzadeh P; Abnous K; Taghdisi SM
    Anal Biochem; 2019 Jun; 575():1-9. PubMed ID: 30926271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AS1411 aptamer modified carbon dots via polyethylenimine-assisted strategy for efficient targeted cancer cell imaging.
    Kong T; Zhou R; Zhang Y; Hao L; Cai X; Zhu B
    Cell Prolif; 2020 Jan; 53(1):e12713. PubMed ID: 31691382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel AS1411 Aptamer-Based Three-Way Junction Pocket DNA Nanostructure Loaded with Doxorubicin for Targeting Cancer Cells in Vitro and in Vivo.
    Taghdisi SM; Danesh NM; Ramezani M; Yazdian-Robati R; Abnous K
    Mol Pharm; 2018 May; 15(5):1972-1978. PubMed ID: 29669200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.
    Alibolandi M; Taghdisi SM; Ramezani P; Hosseini Shamili F; Farzad SA; Abnous K; Ramezani M
    Int J Pharm; 2017 Mar; 519(1-2):352-364. PubMed ID: 28126548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoaggregate-forming lipid-conjugated AS1411 aptamer as a promising tumor-targeted delivery system of anticancer agents in vitro.
    Carvalho J; Lopes-Nunes J; Vialet B; Rosado T; Gallardo E; Vale J; Eloy C; Ferreira S; Palmeira-de-Oliveira R; Campello MPC; Paulo A; Barthélémy P; Mergny JL; Salgado GF; Queiroz JA; Ellington AD; Cruz C
    Nanomedicine; 2021 Aug; 36():102429. PubMed ID: 34174419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.